Patent · US Expired

Pyrrolidine derivatives

US6790860B2 · kind B2 · utility

5Cited by

0References

23Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Johannes Aebi · Binningen, CH
Daniel Bur · Therwil, CH
Alexander Chucholowski · San Diego, US
Henrietta Dehmlow · Weil am Rhein, DE
Eric A. Kitas · Aesch, CH
Ulrike Obst · Weil am Rhein, DE
Hans Peter Wessel · Heitersheim, DE

Key dates

Filing date	Feb 25, 2003
Grant date	Sep 14, 2004
Priority date	—
Expiry date	Feb 25, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pyrrolidine derivatives useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in treating disease states associated with vasoconstriction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.